Search for: "Lee v. McNeil" Results 1 - 20 of 20
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jan 2008, 7:22 am
Charlie Crist has yet to name McNeil's successor at the Department of Juvenile Justice, which McNeil managed without scandal a year after the last high-profile death of a child, 14-year-old Martin Lee Anderson, occurred under his predecessor. [read post]
9 Mar 2009, 7:06 am
McNeil (08-7369) involved William Lee Thompson, who is awaiting execution for the 1976 murder of a woman who failed to obtain money that Thompson and another man demanded from her family. [read post]
8 Sep 2011, 12:00 pm by Bexis
Ohio Aug. 12, 2011) (oral contraceptive – back to Taiwan); Lee v. [read post]
26 Apr 2022, 4:40 am
McNeil Co., Inc., 270 Neb. 241, 700 N.W.2d 608 (2005); Yanni v. [read post]
26 Apr 2020, 4:25 pm by INFORRM
  The case had been tried last month but the settlement took place before Justice Michael Lee had handed down judgment. [read post]
2 Oct 2015, 9:09 am by Ed. Microjuris.com Puerto Rico
This decision, The Clorox Company Puerto Rico v. [read post]
31 Mar 2010, 1:58 pm
The words "score line" do not appear in independent claim 1 of the Lee patents. [read post]
10 Nov 2011, 7:10 pm by Kiera Flynn
McNeil Docket: 11-295 Issue: (1) Whether the court below properly held that counsel’s failure to strike an openly biased juror does not constitute objectively unreasonable performance under Strickland v. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
25 Jan 2008, 1:00 am
: (IP ThinkTank),IBM patents and defensive publishing: (Securing Innovation),Stockholm Network paper on developing nations and pharmaceutical patents: (IPcentral Weblog),Good and bad news for the IP industry if recession does bite: (IAM),Business Software Alliance: Piracy economic impact is tens of billions of dollars: (Ars Technica),IP portfolio costs - when less is more: (IP ThinkTank),IP protection: Competitive market default: (The Fire… [read post]